Quantcast
Home > Quotes > STIM
STIM

Neuronetics, Inc. Common Stock (STIM) Quote & Summary Data

$19.88
*  
0.79
3.82%
Get STIM Alerts
*Delayed - data as of Dec. 12, 2018 14:11 ET  -  Find a broker to begin trading STIM now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    STIM Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 19.83 / $ 19.94
Today's High / Low
$ 20.99 / $ 19.75
Share Volume
82,372
50 Day Avg. Daily Volume
128,545
Previous Close
$ 20.67
52 Week High / Low
$ 39.39 / $ 15.40
Market Cap
349,480,281
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
82,372
50 Day Avg. Daily Volume:
128,545

Trading Range

The current last sale of $19.88 is 29.09% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 20.99 $ 39.39
 Low: $ 19.75 $ 15.40

Company Description (as filed with the SEC)

We are a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemicoffice-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, to treat adult patients with major depressive disorder, or MDD, that have failed to achieve satisfactory improvement from prior antidepressant medication in the current MDD episode. NeuroStar Advanced Therapy is safe, clinically effective, reproducible and precise and we believe is supported by the largest clinical data set of any competing TMS system.  ... More ...  


Risk Grade

Where does STIM fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 20.99
Open Date:
Dec. 12, 2018
Close Price:
$ 20.67
Close Date:
Dec. 11, 2018

Consensus Recommendation

Analyst Info